Skip to content
Home/Companies/TMT/Eurocept Pharmaceuticals
EP

Eurocept Pharmaceuticals

TMT·Netherlands·Exited 2022

Eurocept Pharmaceuticals is a TMT company, headquartered in Netherlands.

Entry
–
Hold
–
Exit
2022
Est. EV
–

Who owns Eurocept Pharmaceuticals?

Eurocept Pharmaceuticals was owned by Gimv.

Hand-verified · updated 2026-04-21

Gimv
Investor
Gimv
Fund attribution unclassified.

Key facts

HQNetherlands
SectorTMT
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2022

More from Gimv Portfolio

Other portfolio companies in the same fund.

Ablynx
Exited 2013
TMTBelgium
Acceo
Active
TMTBelgium
Acertys Group
Exited 2015
TMTBelgium
to
ActoGeniX
Exited 2015
TMTBelgium
to
AgroBiothers
Active
TMTBelgium
Almaviva
Exited 2017
TMTBelgium
to

More PE-backed in TMT

Comparable tmt deals from other GPs.

1500h
Active
QUANTONATION VENTURESFrance
24ORE
Active
FemuQui VenturesFrance
2Checkout (Avangate)
Exited
Francisco PartnersUS
3878 Best
Active
QUANTONATION VENTURES
3Bee
Active
AgFunderUS
3ma group
Active
Isatis CapitalFrance
Data refreshed weekly · Sourced from public filings